H. Megen

Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients

H. Westenberg, J. A. Boer, M. Traub, 1994, Psychopharmacology.

The panic-inducing properties of the cholecystokinin tetrapeptide CCK4 in patients with panic disorder

H. Westenberg, J. A. Boer, R. Kahn, 1996, European Neuropsychopharmacology.

Effect of the cholecystokinin-B receptor antagonist L-365,260 on lactate-induced panic attacks in panic disorder patients

H. Westenberg, J. A. Boer, H. Megen, 1996, Biological Psychiatry.

On the significance of cholecystokinin receptors in panic disorder

H. Westenberg, J. A. Boer, H. Megen, 1994, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Cholecystokinin in anxiety

H. Westenberg, J. A. Boer, R. Kahn, 1996, European Neuropsychopharmacology.

Differential effects of the D1-DA receptor antagonist SCH39166 on positive and negative symptoms of schizophrenia

H. Westenberg, J. A. Boer, W. Fleischhacker, 1995, Psychopharmacology.

The Netherlands Obsessive Compulsive Disorder Association (NOCDA) study: design and rationale of a longitudinal naturalistic study of the course of OCD and clinical characteristics of the sample at baseline

J. Smit, K. Schruers, D. Cath, 2012, International journal of methods in psychiatric research.

University of Groningen Presence and Predictive Value of Obsessive-Compulsive Symptoms in Anxiety and Depressive Disorders

B. Penninx, N. Batelaan, D. Cath, 2019 .

Obsessive-compulsive and related disorders

H. Megen, O. V. D. Heuvel, 2018 .